BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6230454)

  • 1. Indomethacin sensitive suppressor cells in Crohn's disease: a possible role in decreased lymphocyte responsiveness.
    Victorino RM
    J Clin Lab Immunol; 1983 Aug; 11(4):197-201. PubMed ID: 6230454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
    Auer IO; Röder A; Fröhlich J
    Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced suppressor cell activity in intestinal lymphocytes from patients with Crohn's disease.
    Goodacre RL; Bienenstock J
    Gastroenterology; 1982 Apr; 82(4):653-8. PubMed ID: 7060886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of prostaglandins on lymphocyte transformation in Crohn's disease.
    Echevarría S; Cajigas J; Rodríguez de Lope C; Lozano JL; Pons Romero F
    Allergol Immunopathol (Madr); 1989; 17(6):317-21. PubMed ID: 2635833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's disease.
    James SP; Neckers LM; Graeff AS; Cossman J; Balch CM; Strober W
    Gastroenterology; 1984 Jun; 86(6):1510-8. PubMed ID: 6232165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional suppressor T cell activity in Crohn's disease and the effects of sulphasalazine.
    Holdstock G; Chastenay BF; Krawitt EL
    Clin Exp Immunol; 1982 Jun; 48(3):619-24. PubMed ID: 6126286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on lymphocyte hyporesponsiveness in cirrhosis: the role of increased monocyte suppressor cell activity.
    Holdstock G; Chastenay BF; Krawitt EL
    Gastroenterology; 1982 Feb; 82(2):206-12. PubMed ID: 6459260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covert suppressor T cells in Crohn's disease.
    Elson CO; Graeff AS; James SP; Strober W
    Gastroenterology; 1981 Jun; 80(6):1513-21. PubMed ID: 6453036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of suppression of the depressed lymphocyte response in lung cancer patients.
    Alberola V; González-Molina A; Trenor A; San Martín B; Lluch A; Palau F; Marín J; García-Conde FJ
    Allergol Immunopathol (Madr); 1985; 13(3):213-9. PubMed ID: 2931010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor cells in melanoma and lung cancer: correlation with the clinical stage.
    Minassian AA; Kadagidze ZG
    Neoplasma; 1983; 30(2):153-8. PubMed ID: 6221196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoregulatory cell function in peripheral blood leukocytes of patients with intracranial gliomas.
    Braun DP; Penn RD; Flannery AM; Harris JE
    Neurosurgery; 1982 Feb; 10(2):203-9. PubMed ID: 6280097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of the serum immunosuppressive factor by monocytes in patients with Crohn's disease.
    Watanabe M; Hibi T; Iwao Y; Kanai T; Ohara M; Fujisawa T; Ogata H; Watanabe N; Asakura H; Aiso S
    J Clin Lab Immunol; 1989 Aug; 29(4):161-6. PubMed ID: 2637362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activation of the major omentum-associated lymphoid tissue in Crohn disease].
    Schreiber S; Gehrckens A; Raedler A
    Zentralbl Chir; 1995; 120(2):135-44. PubMed ID: 7709665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogenic response and interleukin 2 production in Crohn's disease.
    Miura M; Hiwatashi N
    J Clin Lab Immunol; 1987 Nov; 24(3):113-6. PubMed ID: 3501474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological suppressor cell activity in insulin dependent diabetes.
    Slater LM; Murray SL; Kershnar A; Mosier MA
    J Clin Lab Immunol; 1980 Mar; 3(2):105-9. PubMed ID: 6451707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [T-lymphocyte subpopulations in the peripheral blood of patients with Crohn disease].
    Purrmann J; Hengels KJ; Cleveland S; Gemsa R; Koldehoff M; Strohmeyer G
    Z Gastroenterol; 1990 May; 28(5):242-6. PubMed ID: 2144933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal indomethacin-sensitive suppression in peripheral blood mononuclear cells of cancer patients restricts augmentation by interleukin-2.
    Braun DP; Harris JE
    J Biol Response Mod; 1984 Oct; 3(5):533-40. PubMed ID: 6239013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of cell-mediated immunity in patients with Crohn's disease.
    Surrenti C; Ramarli D; Casini A; Scartabelli S; Campi P; Fani A; Nieri S
    Hepatogastroenterology; 1981 Jun; 28(3):157-9. PubMed ID: 7250897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune dysfunction in primary biliary cirrhosis (PBC): I. Increased sensitivity of PHA stimulated lymphocyte cultures to indomethacin.
    Licastro F; Lenzi M; Chiricolo M; Davis LJ; Cassani F; Bianchi F; Franceschi C
    J Clin Lab Immunol; 1987 May; 23(1):19-23. PubMed ID: 3612758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin-related and adherent cell suppressor system in apparently cured Hodgkin's disease patients.
    Haim N; Meidav A; Samuelly B; Segal R; Mekori T; Robinson E
    J Biol Response Mod; 1984; 3(2):219-25. PubMed ID: 6233397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.